Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Share Buy-Back Programme

11 Jun 2024 07:01

RNS Number : 8774R
B.P. Marsh & Partners PLC
11 June 2024
 

11 June 2024

 

B.P. Marsh & Partners Plc

 

("B.P. Marsh" or the "Company")

 

Share Buy-Back Programme

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, today announces the launch of a new share buy-back programme (the "Programme").

 

Further to the release of the Company's Annual Results, which reconfirmed the Company's intention to undertake on-market share buy-backs to return further capital to shareholders, the Board has today approved the Programme to repurchase ordinary shares of 10 pence each in the Company ("Ordinary Shares") for up to a maximum aggregate consideration of £1 million and subject to Ordinary Shares being available to purchase at a price representing a discount of at least 15% to the most recently announced diluted NAV per share prevailing at the time of repurchase.

 

The Programme will be carried out in accordance with the Company's general authority to purchase a maximum of 3,746,600 Ordinary Shares, granted by shareholders at the Company's Annual General Meeting which was held on 26 July 2023 (the "General Authority"), since when the Company has purchased 97,652 Ordinary Shares.

 

This General Authority expires at the Company's next Annual General Meeting to be held in July 2024 (the "2024 AGM"), at which the Company expects to seek shareholders' approval authorising another such general authority for a further 12 months, or, if earlier, at the close of business on 31 July 2025 (being, if approved, also a "General Authority"), subject to which the Programme will continue beyond the 2024 AGM in accordance with the renewed General Authority and the parameters set out above.

 

The purpose of the Programme is to reduce the Company's share capital and it will commence on the date of this announcement and continue until either the maximum pecuniary amount has been purchased under the Programme or, if earlier, the expiration of the relevant General Authority.

 

The Company has entered into an irrevocable commitment with Panmure Gordon (UK) Limited to conduct the Programme and repurchase Ordinary Shares on the Company's behalf and to make trading decisions under the Programme in accordance with certain pre-set parameters independently of the Company.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out. Under the Programme, the repurchased shares will be held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and the delegated regulations made pursuant to it. The Company confirms that it currently has no unpublished price sensitive information.

 

The Company will announce any market purchase of Ordinary Shares pursuant to the Programme without delay.

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least ten years.

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFSIRTIILIS
Date   Source Headline
24th Feb 20257:00 amRNSTrading Statement
14th Feb 20252:58 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSInterim Dividend Declaration
8th Jan 202510:20 amRNSDirector/PDMR Shareholding
6th Jan 202512:00 pmRNSDirector/PDMR Shareholding
12th Dec 20243:18 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSFollow on Investment – XPT Group LLC
12th Nov 20249:36 amRNSDirector/PDMR Shareholding
31st Oct 20245:45 pmRNSCancellation of Shares & Buy-Back Programme Update
30th Oct 20247:00 amRNSNew Investment – SRT & Partners Limited
29th Oct 202412:40 pmRNSFollow on Investment – Pantheon Specialty Group
29th Oct 20249:40 amRNSSale of Lilley Plummer Holdings Limited
23rd Oct 20247:00 amRNSHalf Year Results
14th Oct 20247:00 amRNSNew Investment – Volt UW HoldCo Ltd
11th Oct 202410:10 amRNSTransaction in Own Shares
9th Oct 202410:00 amRNSNotice of HY Results and Investor Presentation
7th Oct 20244:03 pmRNSTransaction in Own Shares
1st Oct 20243:37 pmRNSTransaction in Own Shares
1st Oct 202411:04 amRNSTransaction in Own Shares
30th Sep 20242:20 pmRNSNew Investment – CEE Specialty s.r.o.
30th Sep 20249:00 amRNSTransaction in Own Shares
27th Sep 20241:10 pmRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 202412:05 pmRNSTransaction in Own Shares
19th Sep 20245:02 pmRNSTransaction in Own Shares
18th Sep 20243:15 pmRNSTransaction in Own Shares
18th Sep 20243:00 pmRNSDirector/PDMR Shareholding
17th Sep 20245:00 pmRNSTransaction in Own Shares
17th Sep 20247:02 amRNSTransaction in Own Shares
17th Sep 20247:01 amRNSAppointment of Joint Corporate Broker
17th Sep 20247:00 amRNSTrading Statement
16th Sep 20242:15 pmRNSDirectorate Change
13th Sep 20243:04 pmRNSTransaction in Own Shares
10th Sep 20241:43 pmRNSTransaction in Own Shares
5th Sep 20242:00 pmRNSDirectorate Change
5th Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20245:05 pmRNSTransaction in Own Shares
2nd Sep 202410:09 amRNSTransaction in Own Shares
27th Aug 20243:15 pmRNSTransaction in Own Shares
13th Aug 20249:33 amRNSTransaction in Own Shares
6th Aug 20244:25 pmRNSTransaction in Own Shares
5th Aug 20242:03 pmRNSTransaction in Own Shares
5th Aug 20249:20 amRNSDirector/PDMR Shareholding
2nd Aug 20248:45 amRNSShare Buy-Back Programme Update
23rd Jul 20242:35 pmRNSResult of AGM
19th Jul 20242:32 pmRNSTransaction in Own Shares
18th Jul 202411:19 amRNSTransaction in Own Shares
16th Jul 20243:20 pmRNSTransaction in Own Shares
12th Jul 20248:35 amRNSTransaction in Own Shares
10th Jul 20242:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.